Neuropathix Revenue and Competitors
Estimated Revenue & Valuation
- Neuropathix's estimated annual revenue is currently $301.5k per year.
- Neuropathix's estimated revenue per employee is $50,250
- Neuropathix's total funding is $4.5M.
Employee Data
- Neuropathix has 6 Employees.
- Neuropathix grew their employee count by -14% last year.
Neuropathix's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder & Chief Communications Officer | Reveal Email/Phone |
2 | Chief Chemist | Reveal Email/Phone |
3 | Chief Communications Officer | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
Neuropathix Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $43.2M | 215 | 6% | N/A | N/A |
#2 | $81.8M | 407 | 10% | N/A | N/A |
#3 | $11.7M | 58 | 0% | N/A | N/A |
#4 | $1011.8M | 5034 | -9% | N/A | N/A |
#5 | $44.8M | 223 | 1% | N/A | N/A |
#6 | $13.1M | 65 | 5% | N/A | N/A |
#7 | $16.5M | 82 | 41% | N/A | N/A |
#8 | $17.3M | 86 | -5% | N/A | N/A |
#9 | $67.9M | 402 | 30% | N/A | N/A |
#10 | $14.9M | 74 | 7% | N/A | N/A |
What Is Neuropathix?
Neuropathix is a biopharmaceutical company focused on the research and development of a pipeline of next generation socially responsible pain management therapeutics to treat patients with significant unmet medical needs.
keywords:N/A
$4.5M
Total Funding
6
Number of Employees
$301.5k
Revenue (est)
-14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Neuropathix News
2022-04-06 - 2022-04-13 | OTCQB:NPTX | Press Release | Neuropathix Inc
Neuropathix, Inc. Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019. NPTX | 10 days ago.
2022-04-06 - Neuropathix, Inc. Highlights Positive Preclinical Study Results ...
Neuropathix, Inc. Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019. By. ACCESSWIRE.
2022-03-30 - Medical Marijuana, Inc. Provides Update on its Pharmaceutical Initiatives
Neuropathix (OTCQB: NPTX), a major investment of Medical Marijuana, Inc. and a socially responsible pain management life sciences company,...
Other Companies in Doylestown
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.6M | 6 | N/A | N/A |
#2 | $0.4M | 6 | 0% | N/A |
#3 | $0.4M | 6 | 0% | N/A |
#4 | $0.5M | 7 | 0% | N/A |
#5 | $0.6M | 8 | -20% | N/A |